RxDoctor Payments Data

Kendra Phillis, OD

Optometrist · Boston, MANPI 1942868666

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (44.4%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Alcon at 33.4% of the total. Reporting peaked in 2024 at $1,196 and has fallen 80.6% since, to $233 in 2025. Among optometrist clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,047in general payments, 2019–2025

Across 93 payments — averaging $43.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$1K
  • Coopervision Inc.$946
  • Johnson & Johnson Vision Care, Inc.$717
  • Bausch & Lomb Americas Inc.$342
  • Oyster Point Pharma, Inc.$182
  • Dompe US, Inc.$146
  • plus $363 from 10 others

What the payments were for

  • Consulting fees$1,35033%
  • Speaking & faculty fees$90022%
  • Food & beverage$1,79744%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,047 in reported general payments places this provider in the 90th percentile of 1,084 optometrist providers in Massachusetts.

See all optometrist providers in Massachusetts →

Medicare billing

Part B allowed, 2024
$48,101
Medicare patients
224
Services billed
704

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost23$225

Paid to pharmacies, not to this prescriber.

Other optometrist in Boston

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →